These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 1081957)
1. [Behavior of antinuclear factors in the scleroderma]. Barthelmes H Dermatol Monatsschr; 1975 Jul; 161(7):536-44. PubMed ID: 1081957 [No Abstract] [Full Text] [Related]
2. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases. Diaz Gill GA; Beutner EH; Eisenberg RB Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867 [No Abstract] [Full Text] [Related]
3. [Demonstration of antinuclear factors using the immunologic enzyme technic]. Storch H Z Gesamte Inn Med; 1973 Jan; 28(2):29-32. PubMed ID: 4120838 [No Abstract] [Full Text] [Related]
4. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis]. Zitnan D; Rovenský J; Cebecauer L; Hajzok O Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583 [No Abstract] [Full Text] [Related]
5. [Immunofluorescence study with an autoantinucleolus antiserum from a scleroderma patient as compared with silver staining]. Young Y Shi Yan Sheng Wu Xue Bao; 1986 Mar; 19(1):39-51. PubMed ID: 2426879 [No Abstract] [Full Text] [Related]
7. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients]. Nebe H; Blume N Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251 [No Abstract] [Full Text] [Related]
8. [Types of anticellular structure antisera in scleroderma patients]. Ni ZM Zhonghua Yi Xue Za Zhi; 1993 May; 73(5):270-2, 318. PubMed ID: 8221243 [TBL] [Abstract][Full Text] [Related]
9. [Antinuclear antibodies in patients with systemic scleroderma]. Wranicz A; Defecińska-Trzeciak E Przegl Dermatol; 1972; 59(3):315-20. PubMed ID: 4538127 [No Abstract] [Full Text] [Related]
10. [Anti-DNA antibodies; results of a new method of detection using the fluorescent antibody technic]. Kahn MF; Peltier AP; Haim T; Marcheteau M; de Sèze S Rev Rhum Mal Osteoartic; 1973 Jun; 40(6):393-8. PubMed ID: 4580290 [No Abstract] [Full Text] [Related]
14. Antinuclear antibody staining only centrioles in a patient with scleroderma. Osborn TG; Patel NJ; Ross SC; Bauer NE N Engl J Med; 1982 Jul; 307(4):253-4. PubMed ID: 7045664 [No Abstract] [Full Text] [Related]
15. Anti-NuMA antibodies: an uncommon specificity in scleroderma sera. Herrera-Esparza R; Avalos-Diaz E; Barbosa-Cisneros O Rev Rhum Engl Ed; 1999 Jun; 66(6):315-8. PubMed ID: 10418059 [TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibodies: their significance in scleroderma. Jordon RE; Deheer D; Schroeter A; Winkelmann RK Mayo Clin Proc; 1971 Feb; 46(2):111-3. PubMed ID: 4925983 [No Abstract] [Full Text] [Related]
17. Renal immune deposits in scleroderma. McGiven AR; De Boer WG; Barnett AJ Pathology; 1971 Apr; 3(2):145-50. PubMed ID: 4937698 [No Abstract] [Full Text] [Related]
18. Detection of human antinuclear antibodies on rodent omenta. Holub M Allerg Immunol (Leipz); 1982; 28(2):118-21. PubMed ID: 6182782 [TBL] [Abstract][Full Text] [Related]
19. [Sclerodermal and the centromere antibody]. Ullman S; Rasmussen E; Høier-Madsen M; Wiik A; Halberg P Ugeskr Laeger; 1988 Jul; 150(28):1743-6. PubMed ID: 3260421 [No Abstract] [Full Text] [Related]
20. [Development of antinuclear antibodies in an acute scleroderma crisis]. Fortin F; Pagniez D; Mac Namara E; Dupriez B; Dequiedt P Nephrologie; 1987; 8(1):30. PubMed ID: 3495742 [No Abstract] [Full Text] [Related] [Next] [New Search]